Posted by Michael Wonder on 29 Jan 2020
Teva announces FDA approval of Ajovy (fremanezumab-vfrm) injection auto-injector
28 January 2020 - Teva Pharmaceuticals USA today announced that the FDA has approved an auto-injector device for Ajovy (fremanezumab-vfrm) injection.
The Ajovy auto-injector is expected to be available to patients in the coming months.
